Inicio > Medicina > Medicina clínica e interna > Cosa fa sì che i pazienti continuino a prendere i farmaci anticonvulsivanti quando non sono in ospedale
Cosa fa sì che i pazienti continuino a prendere i farmaci anticonvulsivanti quando non sono in ospedale

Cosa fa sì che i pazienti continuino a prendere i farmaci anticonvulsivanti quando non sono in ospedale

Deogratias Katabalo

83,04 €
IVA incluido
Disponible
Editorial:
KS OmniScriptum Publishing
Año de edición:
2025
Materia
Medicina clínica e interna
ISBN:
9786209343360
83,04 €
IVA incluido
Disponible
Añadir a favoritos
Sobre IBD

È super importante che i bambini con epilessia seguano bene la terapia con farmaci anticonvulsivanti, perché un sacco di studi hanno dimostrato che l’epilessia si può curare nel 70% dei casi se si prendono i farmaci tradizionali per 2-5 anni. Però, per farlo bene, ci vuole un lavoro di squadra tra medici, genitori/tutori e pazienti. Questo studio ha guardato quanto i bambini seguono la terapia e cosa influenza questo. Si tratta di informazioni importanti per gli operatori sanitari e i genitori o i tutori dei bambini affetti da epilessia.

Artículos relacionados

  • Occupational Therapy in Critical Care Units
    Natalia Montes Silva
    The presence of Occupational Therapists in Critical Patient Units increased significantly during the COVID-19 pandemic, making visible the importance of the professional in the early rehabilitation of people in different health conditions who are hospitalized in the CPU. Thus, among the topics addressed are the health model in Chile, the role of the OT in the PCU and the scient...
    Disponible

    52,90 €

  • MULLER MATRIX IMAGES OF BIOLOGICAL CRYSTAL NETWORKS
    Dmytro Uhryn / Yurii Tomka / Yurii Ushenko
    This research explores the optical characterization of biological tissues, distinguishing them as highly scattering (opaque) or weakly scattering (transparent). The focus is on Mueller matrix imaging (MMI), offering detailed polarization information. The goal is to extend traditional photometric methods by incorporating MMI coordinate distributions, providing exhaustive insight...
    Disponible

    99,53 €

  • Change Dynamics in Healthcare, Technological Innovations, and Complex Scenarios
    Darrell Norman Burrell
    In a world characterized by complexity and rapid change, the intersection of healthcare, social sciences, and technology presents a formidable challenge. The vast array of interconnected issues, ethical dilemmas, and technological advancements often evade comprehensive understanding within individual disciplines. The problem lies in the siloed approach to these critical domains...
    Disponible

    660,19 €

  • INVISIBLE BATTLEFIELD
    NATALYA RAPOPORT / RAPOPORT NATALYA
    Invisible Battlefield: A Global History of Epidemics is not simply a retelling of history; the book takes the reader on a riveting journey through the harrowing landscape of pandemics, offering a profound exploration of the far-reaching consequences of epidemics throughout history. Chapter by chapter, the book navigates the intersection of medical history, ethical dilemmas, and...
    Disponible

    71,46 €

  • INVISIBLE BATTLEFIELD
    NATALYA RAPOPORT / RAPOPORT NATALYA
    Invisible Battlefield: A Global History of Epidemics is not simply a retelling of history; the book takes the reader on a riveting journey through the harrowing landscape of pandemics, offering a profound exploration of the far-reaching consequences of epidemics throughout history. Chapter by chapter, the book navigates the intersection of medical history, ethical dilemmas, and...
    Disponible

    33,62 €

  • Die Information des Patienten vor der Dialyse und die Überweisung zur Dialyse
    Mohamed Lamine Kourouma
    Wir betonen in dieser Erzählung den positiven Charakter, den eine Information vor der Dialyse auf die Optimierung des Managements der terminalen Niereninsuffizienz haben kann. Dies kann sich in der 'Wahl des Patienten' hinsichtlich der Dialysemethode äußern. Gleichzeitig weisen wir auf die mangelnde Sichtbarkeit der Peritonealdialyse hin. Diese Studie folgt auf mehrere Errungen...
    Disponible

    52,90 €

Otros libros del autor

  • Czynniki determinujące przestrzeganie terapii przeciwdrgawkowej w warunkach ambulatoryjnych
    Deogratias Katabalo
    Przestrzeganie zaleceń dotyczących przyjmowania leków przeciwdrgawkowych przez dzieci cierpiące na epilepsję jest niezwykle istotne, ponieważ wiele badań wykazało, że epilepsja jest chorobą uleczalną u 70 procent pacjentów, którzy przestrzegają zaleceń dotyczących przyjmowania konwencjonalnych leków przez okres od 2 do 5 lat. Jednakże osiągnięcie pełnej zgodności z zaleceniami ...
    Disponible

    83,04 €

  • Fatores que influenciam a adesão à terapia com anticonvulsivantes em pacientes ambulatoriais
    Deogratias Katabalo
    A adesão aos anticonvulsivantes por crianças com epilepsia é super importante, porque várias pesquisas mostram que a epilepsia é uma doença que dá para tratar em 70% dos pacientes que tomam os remédios convencionais por um período de 2 a 5 anos. Mas, para conseguir uma adesão total, é preciso o trabalho conjunto dos profissionais de saúde, pais/responsáveis e pacientes. Este tr...
    Disponible

    82,98 €

  • Was beeinflusst, ob Leute bei der Behandlung mit Antikonvulsiva bleiben, wenn sie ambulant behandelt werden?
    Deogratias Katabalo
    Die Einhaltung der Medikamenteneinnahme bei Kindern mit Epilepsie ist echt wichtig, weil viele Studien gezeigt haben, dass Epilepsie bei 70 Prozent der Patienten, die ihre Medikamente über 2 bis 5 Jahre nehmen, gut behandelt werden kann. Aber damit das klappt, müssen Ärzte, Eltern/Erziehungsberechtigte und Patienten zusammenarbeiten. Diese Studie hat geschaut, wie gut Kinder ih...
    Disponible

    83,04 €

  • Facteurs qui influencent l’adhésion au traitement anticonvulsivant chez les patients en ambulatoire
    Deogratias Katabalo
    Il est super important que les enfants épileptiques prennent bien leurs médicaments anticonvulsivants, car plein d’études ont montré que l’épilepsie peut être soignée chez 70 % des patients qui suivent un traitement classique pendant 2 à 5 ans. Mais pour que ça marche vraiment, il faut que les pros de la santé, les parents/tuteurs et les patients bossent ensemble. Cette étude a...
    Disponible

    83,04 €